Different cohort studies documented a lower glomerular filtration rate (GFR) in former extremely low birth weight (ELBW, <1000 g) neonates throughout childhood when compared to term controls. The current aim is to pool these studies to describe the GFR pattern over the pediatric age range. To do so, we conducted a systematic review on studies reporting on GFR measurements in former ELBW cases while GFR data of healthy age-matched controls included in these studies were co-collected. Based on 248 hits, 6 case-control and 3 cohort studies were identified, with 444 GFR measurements in 380 former ELBW cases (median age 5.3-20.7 years). The majority were small (17-78 cases) single center studies, with heterogeneity in GFR measurement (inulin, Cystatin C or creatinine estimated GFR formulae) tools. Despite this, the median GFR (ml/kg/1.73m 2 ) within casecontrol studies was consistently lower (-13, range -8 to -25%) in cases, so that a relevant minority (15-30%) has chronic kidney disease ≥stage 2 (GFR <90 ml/kg/1.73m 2 ). Consequently, this pooled analysis describes a pattern of reduced GFR in former ELBW cases throughout childhood. Research should focus on perinatal risk factors for impaired GFR and long-term outcome, but is hampered by single center cohorts, study size, and heterogeneity of tools.
preterm birth by preterm birth itself, as well as perinatal events, so that former preterm infants have a decreased radial glomerular count compared to term cases [3, 4] . Brenner et al. has put forward the concept ('Brenner hypothesis') that nephron endowment and subsequent single nephron hyperfiltration is a significant factor in the pathogenesis of subsequent chronic kidney disease (CKD) and hypertension [3, 4, 5] . As preterm birth disturbs glomerulogenesis and nephron endowment, it is a risk factor for CKD and it may be useful to follow-up the renal function in former ELBW children, with glomerular filtration rate (GFR) as the most obvious indicator of renal function [3, 4, 5] .
As we know, GFR can be measured or estimated. GFR measurement by exogenous markers such as inulin, iohexol, mannitol, Cr-EDTA or iothalamate is still the golden standard, but this has its burdens and limitations as screening tool [6, 7] . Therefore, GFR is more commonly estimated (eGFR) by endogenous markers like serum creatinine (SCr) or cystatic C (CysC). The SCr-based GFR equation is hereby mostly used, with the CysC-based GFR equations as valid alternatives. The combination of both (SCr-CysC-based GFR equation) has a higher accuracy and precision, also in children [8] . The assessment of (e)GFR in former ELBW children throughout childhood has reported in observational studies, sometimes compared to age-matched controls. The current aim is to pool these studies to describe the GFR trend over the pediatric age range in former ELBW cases.
Materials and Methods
This systematic review was conducted along the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [9] . To be eligible, participants in the included studies had to be former ELBW newborns, with an age range from infancy until young adulthood and GFR outcome data. Healthy age-matched peers (born term with a normal birth weight) included in these studies as controls were co-enrolled in this analysis to facilitate comparison of GFR between these cases and controls. Embase: ('extremely low birth weight':ti,ab,kw OR 'extremely preterm infant':ti,ab,kw) AND ('kidney function':ti,ab,kw OR 'kidney function test':ti,ab,kw OR 'cystatin c':ti,ab,kw OR 'creatinine':ti,ab,kw OR 'glomerulus filtration rate':ti,ab,kw OR 'kidney failure':ti,ab,kw OR 'chronic kidney failure':ti,ab,kw); Web of Science: ("Infant, Extremely Low Birth Weight" OR elbw OR "extremely low birth weight" OR "extremely preterm" OR "extremely low birthweight") AND ("Kidney Function Articles were screened based on title, abstract and finally full text containing information about participants (specific ELBW children, with a GFR assessment), while studies including but not reporting specific on GFR outcome in ELBW cases were not included) by the first author (EG), and uncertainties were discussed with the final author (KA) until agreement. For the full papers retained in the search, the reference list and list of citing articles were screened.
The STROBE statement checklist (Strengthening the Reporting of Observational Studies in Epidemiology) to evaluate the quality of the obtained articles and to assess the risk of bias (cohort, case-control) were used [10] . Additional quality assessment was performed, using the Newcastle-Ottawa assessment scale for case-control or cohort studies respectively [11] .
From the individual papers, the following data were extracted and tabulated: study design, study size, year of birth, current age of the patient population, birth weight of the patient population, outcome parameters and results (also others than GFR), exclusion criteria, GFR measurement (including technique and/or estimation formula used) summary of reported findings and we searched if the researchers had adjusted for covariates. The mean/median GFR or eGFR values mentioned in the included articles were extracted to plot the GFR values over the pediatric age range.
Data extraction was performed by the first author (EG), and verified by the final author (KA), and differences were discussed until agreement.
Results
Following the search strategy described, 248 (232 + 16) hits were analyzed to result in 6 casecontrol and 3 ELBW cohort studies for the analysis [Figure 1 ]. The key characteristics of the individual case-control studies are provided in Table 1 [12] [13] [14] [15] [16] [17] . One study (Krakow cohort) collected Cys C values in the same cohort at the age of 7 and 11 years, and calculated eGFR values in the latest paper [14, 18] . To provide a full overview on the characteristics, the data reported at the age of 7 years were added to Besides the GFR values, data on other aspects of renal and general outcome (like renal ultrasound, renal tubular functions, blood pressure, biometry and body composition) were coreported. Some papers aimed to explore perinatal risk factors like birth weight, small-for-gestational age (SGA), perinatal growth, Apgar score, indomethacin/ibuprofen or steroid use, or gestational age, but any firm conclusion on these risk factors remained hampered by the cohort sizes.
Quality assessment based on the case-control and cohort study STROBE checklist resulted in moderate to high scores of the nine observational studies retained in the analysis. Five of the papers explicitly discussed risks of biases in the recruitment strategy [13, 15, 16, 17, 20] . In many studies, it was not entirely clear how patient selection and follow-up have been conducted. The assessment of these studies using the Newcastle-Ottawa scale (selection, comparability, outcome) also suggests moderate to high scores [ Table 3 ]. analysis. Questions related to selection (Q1-4), comparability (Q5) and outcome (Q6-Q8) [11] . *= response rate as mentioned in the source document, for cases (n.a.: not applicable).
Discussion
Using a systematic review on cohort studies reporting on GFR measurements in 380 former ELBW cases throughout pediatric life, the GFR (ml/kg/1.73m 2 ) was consistently lower in cases (median -13 %, range, -8 to -25 %). The median decrease (-13 %) is similar to a shift of (e)GFR estimates of about 0.5 to 1 SD, so that a relevant minority (15-30 %) of former ELBW cases has chronic kidney disease (CKD) ≥stage 2 (GFR <90 ml/kg/1.73m 2 ) [16, 19, 21] . We hereby confirmed the pattern of reduced GFR in former ELBW cases throughout pediatric age in line with the Brenner hypothesis [4, 5] .
To further explore the extent of the relative difference in GFR and potential trends throughout pediatric life, we plotted the mean or median (estimated) GFR in the 6 case-control studies in Figure   2 . As one of the cohorts has been assessed twice, we have added arrows to link these specific casecontrol GFR estimates. The % GFR (median -13 %, range, -8 to -25 %) showed no significant trend of % GFR over age.
Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 19 January 2020 doi:10.20944/preprints202001.0213.v1 Figure 2 . Mean or median (estimated) glomerular filtration rate (eGFR) in the 6 case-control studies over age (years) [12] [13] [14] [15] [16] [17] . The arrows connect the same cohort assessed at the age of 7 and 11 years respectively [17, 18] (ELBW: extreme low birth weight).
Consequently, based on the impaired GFR outcome, clinical research should further explore the perinatal risk factors associated with this outcome, and call for action to further explore the subsequent relevance of these findings beyond pediatric life. However, there are study-related issues that make such an effort difficult.
Despite the fact that the quality assessment of the studies resulted in moderate to high scores,
we still observed major relevant burdens to facilitate effective pooling. First, the source documents did not always provided sufficient information to ensure 'full' inclusions of all ELBW cases, and this may have resulted in additional overrepresentation in SGA cases if only the SGA subgroup could be included in the current pooling effort [13, 17, 19 ]. An obvious next step is to pool based on the individual data. Such an effort should also facilitate the exploration of the association between perinatal characteristics (like birth weight, small-for-gestational age (SGA), Apgar score, indomethacin/ibuprofen or steroid use, or gestational age) and GFR outcome, similar to the effort recently reported to pool the ELBW renal outcome data at the age of 11 years [22] . Second and at least as relevant, such pooling effort needs to consider the heterogeneity in GFR measurement (inulin, Cystatin C or creatinine estimated GFR formulae) tools and assays (Cystatin C, creatinine) used [6, 22] .
Conclusions
Despites the study related limitations to enable pooling (small size, single center, heterogeneity GFR measurements) , the pattern of reduced GFR in former ELBW cases throughout pediatric age has been confirmed. The GFR (ml/kg/1.73m 2 ) was consistently lower in cases (median -13 %, range, -8 to -25 %), similar to a shift of (e)GFR estimates of about 0.5 to 1 SD, so that a relevant minority (15- 30 %) of former ELBW cases has chronic kidney disease (CKD) ≥stage 2 (GFR <90 ml/kg/1.73m 2 ).
Consequently, we should further explore the perinatal risk factors associated with impaired GFR outcome, and the subsequent relevance of these findings beyond pediatric life.
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